Gastrointestinal (GI): NSAIDs that block COX-1 action have correlations with GI problems because of the inhibition from the synthesis of gastroprotective agents like PGE2 and also other prostaglandins. This inhibition contributes to decreased mucin production by gastric epithelial cells, significantly less bicarbonate secretion, and less epithelial cell turnover, amongst other https://quentinl766hzq6.fare-blog.com/profile